Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. [electronic resource]
Producer: 20120618Description: 405-15 p. digitalISSN:- 1538-8514
- Adenocarcinoma -- drug therapy
- Animals
- Antibodies, Monoclonal -- chemistry
- Basigin -- immunology
- Carbocyanines -- chemistry
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Synergism
- Drug Therapy, Combination
- Female
- Fluorodeoxyglucose F18 -- pharmacokinetics
- Humans
- Magnetic Resonance Imaging
- Mice
- Mice, Inbred BALB C
- Mice, SCID
- Microscopy, Fluorescence -- methods
- Multimodal Imaging -- methods
- Pancreatic Neoplasms -- drug therapy
- Positron-Emission Tomography
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- immunology
- Tomography, X-Ray Computed
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.